Article

Refractory Cutaneous Rosai-Dorfman Disease Responsive to Cryotherapy

Author and Disclosure Information

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare, acquired, idiopathic, nonneoplastic histiocytosis. In many cases the skin is involved and treatment is indicated. Various treatment options have been attempted with variable success. We report a case of cutaneous Rosai-Dorfman disease (CRDD) refractory to both topical and intralesional corticosteroid therapy that showed a rapid and remarkable response to cryotherapy. These observations suggest that cryotherapy should be considered as a therapeutic option for CRDD.


 

Recommended Reading

Making ACOs More Palatable: The Policy & Practice Podcast
MDedge Dermatology
U.S. Measles Cases Highest Since 1996
MDedge Dermatology
EHR Report: How Current EHR Initiatives Can Help Shape Buying Decisions
MDedge Dermatology
Skin of Color: Rosacea
MDedge Dermatology
Nonablative Fractional Laser Proves Effective for Actinic Cheilitis
MDedge Dermatology
CMS Proposes Looser E-Prescribing Rules
MDedge Dermatology
HHS: More than $100 Million in EHR Incentives So Far
MDedge Dermatology
AMA President Warns of Doctor Shortage
MDedge Dermatology
Feds Pushing Enrollment for Pre-Existing Condition Insurance Plan
MDedge Dermatology
Commentary: Unreliable Herd Immunity Leads to More Measles
MDedge Dermatology